Market Access News | pharmaphorum

News

NIH Director Bhattacharya will temporarily run CDC

The long months without stable leadership at the CDC in the US look set to continue, as NIH chief Jay Bhattacharya is named acting director.

News

Arrows on grey background pointing left and right

FDA relents and will review Moderna's flu shot

The FDA will start a review of Moderna's flu jab mRNA-1010, after refusing to accept the filing last week, with a new "regulatory approach."

News

FDA starts review of BMS's 'celmod' for multiple myeloma

Bristol Myers Squibb could be months away from bringing the first 'celmod' to market, as the FDA starts a review of iberdomide for multiple myeloma.

News

NICE backs first disease-modifying drug for ARG1 deficiency

Immedica's Loargys is poised to become the first NHS therapy for ultra-rare genetic disorder ARG1 deficiency that can alter the course of the disease.

News

EU approval for new asthma drug Exdensur lifts GSK

EU approval takes GSK a step closer to fulfilling its blockbuster sales hopes for new long-acting respiratory drug Exdensur.

News

UK seeks views on indefinite CE marks for medical devices

The UK has launched a consultation asking whether medical devices with CE marks issued in the EU and sold in GB should be recognised indefinitely.

NIH Director Bhattacharya will temporarily run CDC

FDA relents and will review Moderna's flu shot

FDA starts review of BMS's 'celmod' for multiple myeloma

NICE backs first disease-modifying drug for ARG1 deficiency

EU approval for new asthma drug Exdensur lifts GSK

UK seeks views on indefinite CE marks for medical devices

Trial miss doesn't dent Biogen's faith in Alzheimer's drug

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks